UBS Group’s Athenahealth, Inc. ATHN Stock Holding History

UBS Group’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-135,100	Closed	-$19.3M	–	8467
2018 Q1	$19.3M	Buy	+135,100	New	+$18.5M	0.01%	1192
2016 Q2	–	Sell	-27,400	Closed	-$3.8M	–	8138
2016 Q1	$3.8M	Buy	27,400 +26,200	+2,183%	+$3.59M	﹤0.01%	2105
2015 Q4	$193K	Hold	1,200	–	–	﹤0.01%	4698
2015 Q3	$160K	Hold	1,200	–	–	﹤0.01%	4818
2015 Q2	$138K	Sell	1,200 -100	-8%	-$12K	﹤0.01%	5165
2015 Q1	$155K	Sell	1,300 -200	-13%	-$26.7K	﹤0.01%	5083
2014 Q4	$219K	Buy	+1,500	New	+$188K	﹤0.01%	4965

UBS Group's ATHN Position: Q1 2019 in Review

UBS Group sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 1,361,834 shares — an estimated $180M sold.

UBS Group first reported a position in ATHN in Q4 2014 and held it in 17 quarters. The position peaked at $180M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

UBS Group reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
UBS Group sold 1,361,834 Athenahealth, Inc. shares in Q1 2019, an estimated $180M.
UBS Group first reported a position in Athenahealth, Inc. in Q4 2014 and held it in 17 quarters.
UBS Group's Athenahealth, Inc. position peaked at $180M in Q4 2018.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.